Chicago-based Diagnostic Photonics has recieved $3 million in equity venture capital funding, according to a regulatory filing.
The company’s focus is developing microscopic imaging that uses near-infrared light source technology, which is designed to allow physicians to have a better understanding of where dead tissue exists when performing surgical operations.
With the Rise of AI, What IP Disputes in Healthcare Are Likely to Emerge?
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.
According to the company, its technology “generates diffraction-corrected images of tissue microstructure by solving the mathematical equations governing the physics of light at high speed, transforming defocused images into in-focus ones.”
Diagnostic Photonics, founded in 2008 on technology pioneered at the Beckman Institute for Advanced Science and Technology at the University of Illinois, is still seeking an additional $3 million in funding. A representative was unavailable to comment on how the new funding will be used.
Photo: Screenshot via Diagnostic Photonics